Basis for dosing time-dependent changes in the ocular and systemic absorption of topically applied timolol

Journal of Ocular Pharmacology and Therapeutics

Volumn 12, Issue 2, 1996, Pages 103-113

  Lee, Vincent H L ^a   Yamahara, Hiroshi ^a   Gurny, Robert ^b   Sintzel, Martina B ^c   Martenet, Myriam ^c   Gex Fabry, Marianne ^c   Balant, Luc ^d   Ohdo, Shigehiro ^a   Podder, Samir K ^e  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

^c UNIVERSITY OF GENEVA   (Switzerland)

^d Institutions Geneva   (Switzerland)

^e KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACEPROMAZINE MALEATE; ATROPINE; EYE DROPS; KETAMINE; PENTOBARBITAL; TIMOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORNEA; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; GAMMA SCINTIGRAPHY; INTRAMUSCULAR DRUG ADMINISTRATION; LACRIMAL FLUID; MALE; NONHUMAN; RABBIT; TOPICAL DRUG ADMINISTRATION;

EID: 0029884085     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.1996.12.103     Document Type: Article

References (13)

1. Ohdo, S., Grass, G.M., and. Lee, V.H.L. Improving the ocular: systemic ratio of topical timolol by varying the dosing time. Invest. Ophthalmol. Vis. Sci. 32: 2790-2798, 1991.
2. Chang, S.C. and Lee, V.H.L. Nasal and conjunctival contribu-tions to the systemic absorbtion of topical timolol in the pigmented rabbit: Implications in the design of strategies to maximize the ratio of ocular to systemic absorption. J. Ocular Pharmacol. 3: 159-169, 1987.
3. Patton, T. F. and Robinson, J.R. Influence of topical anesthesia on tear dynamics and ocular bioavailability in albino rabbits. J. Pharm. Sci. 64: 267-271, 1975.
4. Schoenwald, R.D. and Huang, H.S. Corneal penetration behavior of ß-blocking agents I: Physicochemical factors. J. Pharm. Sci. 72: 1266-1272, 1983.
5. Hull, D.S., Hine, J.E., Edelhauser, H.F., and Hyndiuk, R.A. Permeability of the isolated rabbit cornea to corticosteroids. Invest. Ophthalmol. 13: 457-459, 1974.
6. Fullard, R.J. and Carney, L.G. Diurnal variation in human tear enzymes. Exp. Eye Res. 38: 15-26, 1984.
7. Huth, S.W., Miller, M.J., and Leopold, I.H. Calcium and Protein in Tears. Arch. Ophthalmol. 99: 1628-1633, 1981.
8. Carney, L.G. and Hill, R.M. Human tear pH: Diurnal variations. Arch. Ophthalmol. 94: 821-824, 1976.
9. Terry, J. E. and Hill, R.M. Human tear osmotic pressure: Diurnal variations and the closed eye. Arch. Ophthalmol. 96: 120-122, 1978.
10. Sieg, J.W. and Robinson, J.R. Vehicle effects on ocular drug bioavailability II: Evaluation of pilocarpine. J. Pharm. Sci. 66: 1222-1228, 1977.
11. Conrad, J.M., Reay, W.A., Polcyn, E., and Robinson, J.R. Influence of tonicity and pH on lacrimation and ocular drug bioavailability. J. Parent. Drug Assoc. 32: 149-161, 1978.
12. Mikkelson, T.J., Chrai, S.S., and Robinson, J.R. Altered bioavailability of drugs in the eye due to drug-protein interaction. J. Pharm. Sci. 62: 1648-1653, 1973.
13. Lee, Y.H., Kompella, U.S., and Lee, V.H.L. Systemic absorption pathways of topically applied beta adrenergic antagonists in the pigmented rabbit. Exp. Eye Res. 57: 341-349, 1993.